Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests (2018 - 2021)

Amphastar Pharmaceuticals has reported Income from Non-Controlling Interests over the past 4 years, most recently at -$2.4 million for Q4 2021.

  • For Q4 2021, Income from Non-Controlling Interests fell 592.72% year-over-year to -$2.4 million; the TTM value through Dec 2021 reached -$731000.0, down 124.24%, while the annual FY2021 figure was -$1.2 million, 287.25% down from the prior year.
  • Income from Non-Controlling Interests for Q4 2021 was -$2.4 million at Amphastar Pharmaceuticals, down from $1.4 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $6.6 million in Q4 2019 and troughed at -$2.4 million in Q4 2021.
  • A 4-year average of $1.0 million and a median of $870500.0 in 2019 define the central range for Income from Non-Controlling Interests.
  • Biggest five-year swings in Income from Non-Controlling Interests: soared 292.27% in 2019 and later crashed 592.72% in 2021.
  • Year by year, Income from Non-Controlling Interests stood at $1.7 million in 2018, then soared by 292.27% to $6.6 million in 2019, then plummeted by 92.77% to $481000.0 in 2020, then crashed by 592.72% to -$2.4 million in 2021.
  • Business Quant data shows Income from Non-Controlling Interests for AMPH at -$2.4 million in Q4 2021, $1.4 million in Q3 2021, and -$855000.0 in Q2 2021.